Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (31-40 of 328) with videos related to

Pageof 33
Sort By:
Journal of Clinical Microbiology|June 8, 2006
An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infectionLuigi Codecasa, Paola Mantegani, Laura Galli, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 18, 2017
Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
Dario Cattaneo, Massimo Andreoni, Gianpiero Carosi, et al.
Clinical and Diagnostic Laboratory Immunology|November 5, 2002
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significanceFrancesco Broccolo, Simona Bossolasco, Anna M Careddu, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patientsOmbretta Turriziani, Nicola Gianotti, Federica Bambacioni, et al.
European Journal of Endocrinology|December 3, 2005
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled studyLivio Luzi, Elena Meneghini, Sabrina Oggionni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including RibavirinMarco Merli, Emanuela Messina, Stefania Salpietro, et al.
Immunology|October 15, 2009
Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subsetPaola Mantegani, Giuseppe Tambussi, Laura Galli, et al.
Journal of Medical Virology|October 26, 2006
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavirNicola Gianotti, Laura Galli, Anna Danise, et al.
AIDS (London, England)|April 21, 2004
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3aGiulia Morsica, Raffaele Bruno, Sabrina Bagaglio, et al.
AIDS (London, England)|April 16, 2002
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individualsLucinda Furci, Lucia Lopalco, Patrizia Loverro, et al.
Pageof 33

Showing results (31-40 of 328) with videos related to

Sort By:
Pageof 33
Journal of Clinical Microbiology|June 8, 2006
An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infectionLuigi Codecasa, Paola Mantegani, Laura Galli, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 18, 2017
Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
Dario Cattaneo, Massimo Andreoni, Gianpiero Carosi, et al.
Clinical and Diagnostic Laboratory Immunology|November 5, 2002
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significanceFrancesco Broccolo, Simona Bossolasco, Anna M Careddu, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patientsOmbretta Turriziani, Nicola Gianotti, Federica Bambacioni, et al.
European Journal of Endocrinology|December 3, 2005
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled studyLivio Luzi, Elena Meneghini, Sabrina Oggionni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including RibavirinMarco Merli, Emanuela Messina, Stefania Salpietro, et al.
Immunology|October 15, 2009
Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subsetPaola Mantegani, Giuseppe Tambussi, Laura Galli, et al.
Journal of Medical Virology|October 26, 2006
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavirNicola Gianotti, Laura Galli, Anna Danise, et al.
AIDS (London, England)|April 21, 2004
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3aGiulia Morsica, Raffaele Bruno, Sabrina Bagaglio, et al.
AIDS (London, England)|April 16, 2002
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individualsLucinda Furci, Lucia Lopalco, Patrizia Loverro, et al.
Pageof 33